1. ACCORD Study Group, Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575. [Abstract]
  2. Adler AI, Stratton IM, Neil HAW, et al; UK Prospective Diabetes Study Group. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412. [Full Text]
  3. Aggarwal M, Khan IA. Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin 2006; 24:135. [Abstract]
  4. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981. [Abstract]
  5. American Heart Association. Heart Disease and Stroke Statistics – 2010 Update. Dallas, Texas: American Heart Association; 2010. [Full text]
  6. American Heart Association Writing Group Members. Heart Disease and Stroke Statistics— 2010 Update: a report from the American Heart Association. Circulation. 2010;121:e46. [Abstract]
  7. Appel LJ, Moore TJ, Obarzanek E, et al; DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997; 336:1117. [Full text]
  8. Appel LJ, Champagne CM, Harsha DW, et al; PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003; 289:2083. [Full text]
  9. Appel LJ, Wright JT Jr, Greene T, et al; AASK Collaborative Research Group. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010; 363:918. [Abstract]
  10. Barrier PA, Li JT, Jensen NM. Two words to improve physician–patient communication: What else? Mayo Clin Proc 2003; 78:211. [Abstract]
  11. Beckett NS, Peters R, Fletcher AE, et al; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358:1887. [full text]
  12. Bennett H, Laird K, Margolius D, et al. The effectiveness of health coaching, home blood pressure monitoring, and home-titration in controlling hypertension among low-income patients: protocol for a randomized controlled trial. 2009; 9:456. [Abstract]
  13. Black HR, Elliott WJ, Neaton JD, et al. Baseline characteristics and early blood pressure control in the CONVINCE trial. Hypertension 2001; 37:12. [Full text]
  14. Blood Pressure Lowering Treatment Trialists’ Collaboration; Turnbull F, Neal B, Pfeffer M, et al. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 2007; 25:951. [Abstract]
  15. Bobrie G, Postel-Vinay N, Delonca J, Corvol P; SETHI Investigators. Self-measurement and self-titration in hypertension: a pilot telemedicine study. Am J Hypertens. 2007; 20:1314. [Abstract]
  16. Bravata DM, Smith-Spangler C, Sundaram V, et al. Using pedometers to increase physical activity and improve health. A systematic review. JAMA. 2007; 298:2296. [PDF]
  17. Brett KM, Burt CW. Utilization of ambulatory medical care by women: United States, 1997–98. Vital Health Stat 13. 2001;(149):1. [Abstract]
  18. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995; 25:305. [abstract]
  19. Buse JB, Ginsberg HN, Bakris GL, et al; American Heart Association; American Diabetes Association. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115:114. [Abstract]
  20. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008; 51:1403. [Full text]
  21. Canzanello VJ, Jensen PL, Schwartz LL, et al. Improved blood pressure control with a physician-nurse team and home blood pressure measurement. Mayo Clin Proc. 2005; 80:31. [Abstract]
  22. Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009; 169:1748. [Abstract]
  23. Centers for Disease Control and Prevention. Diabetes: successes and opportunities for population-based prevention and control: at a glance 2010. Accessed December 5, 2010. [Link]
  24. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206. [Full text]
  25. Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42:1206. [abstract]
  26. Chrysohoou C, Pitsavos C, Panagiotakos DB, et al. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study. Am J Hypertens. 2004; 17:568. [Abstract]
  27. Connolly SJ, Ezekowitz MD, Yusuf S, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361:1139. [full text]
  28. Curtis KM, Mohllajee AP, Martins SL, Peterson HB. Combined oral contraceptive use among women with hypertension: a systematic review. Contraception. 2006; 73:179. [Abstract]
  29. Cushman WC, Ford CE, Cutler JA, et al; ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2002; 4:393. [abstract]
  30. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393. [Abstract]
  31. Cutler DM, Everett W. Thinking outside the pillbox—medication adherence as a priority for health care reform. N Engl J Med. 2010; 362:1553. [Abstract]
  32. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000; 160:2101. [Abstract]
  33. Douglas JG, Bakris GL, Epstein M, et al; the Hypertension in African Americans Working Group. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003; 163:525. [Abstract]
  34. Dunbar-Jacob J, Erlen JA, Schlenk EA, et al. Adherence in chronic disease. Annu Rev Nurs Res. 2000; 18:48. [Abstract]
  35. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967; 202:1028. [Abstract]
  36. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303:2043. [Abstract]
  37. Elliott WJ, Izzo JL Jr, White WB, et al. Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. J Clin Hypertens 2004; 6:553. [Abstract]
  38. European Heart Rhythm Association; Heart Rhythm Society, Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006; 48:854. [full text]<
  39. Farris KB, Côté I, Feeny D, et al. Enhancing primary care for complex patients. Demonstration project using multidisciplinary teams. Can Fam Physician. 2004; 50:998. [Full text]
  40. Fine LJ, Cutler JA. Hypertension and the treating physician: understanding and reducing therapeutic inertia. Hypertension 2006; 47:319. [Full Text]
  41. Flack JM, Sica DA, Bakris G, et al; on behalf of International Society of Hypertension in Blacks. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010; 56:780. [Abstract]
  42. Fogari R, Zoppi A. New class of agents for treatment of hypertension: focus on direct renin inhibition. Vasc Health Risk Manag 2010; 6:869. [Abstract]
  43. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001; 103:1245. [Full text]
  44. Franklin SS, Gustin W IV, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997; 96:308. [abstract]
  45. Franklin S, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001; 37:869. [abstract]
  46. Franklin SS, Pio JR, Wong ND, et al. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation. 2005; 111:1121. [Full text]
  47. Funnell MM, Anderson RM, Arnold MS, et al. Empowerment: an idea whose time has come in diabetes education. Diabetes Educ. 1991; 17:37. [Abstract]
  48. Furie KL, Kasner SE, Adams RJ, et al; American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010 Oct 21. [Epub ahead of print] [Abstract]
  49. Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, et al. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med. 2008; 168:1159. [Full text]
  50. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285:2864. [abstract]
  51. Geleijnse JM. Vitamin D and the prevention of hypertension and cardiovascular diseases: a review of the current evidence. Am J Hypertens 2010 Sep 16 [Epub ahead of print]. [Abstract]
  52. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Stroke Prevention (ATRIA) Study. JAMA. 2001; 285:2370. [abstract]
  53. Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial [published correction appears in JAMA. 2009;302:1972]. JAMA. 2008; 299:2857. [Abstract]
  54. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med. 2004; 164:2113. [Full text]
  55. Grossman E, Grossman A, Schein MH, et al. Breathing control lowers blood pressure. J Hum Hypertens 2001; 15:263. [Full text]
  56. Gueyffier F, Bulpitt, Boissel JP, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. INDANA Group. Lancet. 1999;353:793. [Abstract]
  57. Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007; 298:874. [Abstract]
  58. Herzlinger RE. Market-Driven Health Care: Who Wins, Who Loses in the Transformation of America’s Largest Service Industry. Reading, MA: Addison-Wesley; 1997. pp. 65–75, 231.
  59. Hsia J, Margolis KL, Eaton CB, et al. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation. 2007; 115:855. [Full text]
  60. Hypertension. theheart.org. INVEST: Mortality hazard with lowest blood pressures in diabetics with CAD? http://www.theheart.org/article/1055859.do Accessed December 19, 2010. [Link]
  61. Ingelsson E, Gona P, Larson MG, et al. Altered blood pressure progression in the community and its relation to clinical events. Arch Intern Med 2008;168:1450. [Abstract]
  62. Ishikawa J, Kario K, Eguchi K, et al; J-MORE Group. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study. Hypertens Res. 2006; 29:679. [Abstract]
  63. Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417. [Abstract]
  64. Jentzer JC, DeWald TA, Hernandez AF. Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol. 2010;56:1527. [Abstract]
  65. Jessup M, Abraham WT, Casey DE, et al. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009; 53: e1. [Full text]
  66. Julius S, Nesbitt SD, Egan B, et al. Feasibility of treating prehypertension with an angiotensin receptor blocker. N Engl J Med 2006; 354:1685. [Full text]
  67. Julius S, Nesbitt SD, Egan BM, et al; Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006; 354:1685. [Full text]
  68. Julius S, Nesbitt S, Egan B, et al; TROPHY study group. Trial of preventing hypertension: design and 2-year progress report. Hypertension. 2004; 44:146. [Full text]
  69. Kahn SL, Angle JF. Adrenal vein sampling. Tech Vasc Interv Radiol. 2010; 13:110. [abstract]
  70. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 1971; 27:335. [Abstract]
  71. Kaplan NM, Victor RG. Kaplan’s Clinical Hypertension. Philadelphia: Lippincott Williams & Wilkins, 2010.
  72. Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension. 2008;51:1149. [Abstract]
  73. King DE, Egan BM, Mainous AG 3rd, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich). 2004; 6:562. [Abstract]
  74. Kithas PA, Supiano MA. Practical recommendations for treatment of hypertension in older patients. Vasc Health Risk Manag. 2010; 6:561. [full text]
  75. Kuruvilla M, Gurk-Turner C. A review of warfarin dosing and monitoring. Proc (Bayl Univ Med Cent). 2001; 14:305. [full text]
  76. LaFleur J, Oderda GM. Methods to measure patient compliance with medication regimens. J Pain Palliat Care Pharmacother. 2004; 18:81. [Abstract]
  77. Lavie-Nevo K, Pillar G. Evening-morning differences in blood pressure in sleep apnea syndrome: effect of gender. Am J Hypertens. 2006; 19:1064. [Abstract]
  78. Lechky O. Persuasion techniques can motivate patients to change eating behaviours, symposium told. CMAJ. 1995; 152:583. [PDF]
  79. Lewington S, Clarke R, Qizilbash N, et al; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903. [Abstract]
  80. Logan AG, McIsaac WJ, Tisler A, et al. Mobile phone-based telemonitoring system improves blood pressure treatment of hypertensive diabetic patients. Circulation. 2010; 122:A18482. [Abstract]
  81. Lüders S, Schrader J, Berger J, et al; PHARAO Study Group. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens. 2008; 26:1487. [Abstract]
  82. Mancia G, De Backer G, Dominiczak A, et al; the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension, the Task Force for the Management of Arterial Hypertension of the European Society of Cardiology. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462. [Full text]
  83. Margolius D, Bodenheimer T. Controlling hypertension requires a new primary care model. Am J Manag Care. 2010; 16:648. [Abstract]
  84. Martin SN, Crownover BK, Kovach FE. Clinical inquiries. What's the best way to motivate patients to exercise? J Fam Pract. 2010; 59:43. [Full text]
  85. McCambridge TM, Benjamin HJ, Brenner JS, et al; Council on Sports Medicine and Fitness. Athletic participation by children and adolescents who have systemic hypertension. Pediatrics. 2010; 125:1287. [Abstract]
  86. Meles E, Giannattasio C, Failla M, et al. Nonpharmacologic treatment of hypertension by respiratory exercise in the home setting. Am J Hypertens 2004; 17:370. [Abstract]
  87. Mathers C, Stevens G, Mascarenhas M. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: World Health Organization; 2009. [Full text]
  88. Mello JA, Gans KM, Risica PM, et al. How is food insecurity associated with dietary behaviors? An analysis with low-income, ethnically diverse participants in a nutrition intervention study. J Am Diet Assoc. 2010; 110:1906. [Abstract]
  89. Messerli FH, Bangalore S, Julius S. Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation. 2008; 117:2706. [abstract]
  90. Messerli FH, Staessen JA, Zannad F. Of fads, fashion, surrogate endpoints and dual RAS blockade. Eur Heart J. 2010; 31:2205. [abstract]
  91. Miller WR.  Motivational interviewing: research, practice, and puzzles. Addict Behav. 1996; 21:835. [Link]
  92. Miller WR, Rollnick S. Ten things that motivational interviewing is not. Behav Cogn Psychother. 2009; 37:129. [Abstract]
  93. Miller WR, Sanchez VC. Motivating young adults for treatment and lifestyle change. In: Howard, G, ed. Issues in Alcohol Use and Misuse in Young Adults. Notre Dame, IN: University of Notre Dame Press; 1993.
  94. Mitchell PL, Parlin RW, Blackburn H. Effect of vertical displacement of the arm on indirect blood-pressure measurement. N Engl J Med. 1964; 271:72. [Abstract]
  95. Muller JE. Circadian variation in cardiovascular events. Am J Hypertens. 1999; 12(2 Pt 2):35S. [Abstract]
  96. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens. 2009; 27:280. [Abstract]
  97. Nabi H, Chastang JF, Lefèvre T, et al. Trajectories of depressive episodes and hypertension over 24 Years: the Whitehall II prospective cohort study. Hypertension.2011; 21. [Epub ahead of print][Abstract]
  98. Nakao N, Yoshimura A, Morita H, et al. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet. 2003; 361:117. [abstract]
  99. National High Blood Pressure, Education Program Working Group Report on High Blood Pressure in Pregnancy. Bethesda, MD: National Institutes of Health. National Heart, Lung, and Blood Institute. NIH Publication No. 00-3029; 2000. [Link]
  100. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114 (2 Suppl 4th Report):555. [Full text]
  101. National Institutes of Health. NIH launches multicenter clinical trial to test blood pressure strategy [news release]. November 26, 2010.
  102. National Kidney Foundation. KDOQI™ clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007; 49:S1. [Full text]
  103. Neri I, Monari F, Sgarbi L, et al. l-Arginine supplementation in women with chronic hypertension: impact on blood pressure and maternal and neonatal complications. J Matern Fetal Neonatal Med 2010; 23:1456. [Abstract]
  104. New England Health Institute. NEHI Research Shows Patient Medication Nonadherence Costs Health Care System $290 Billion Annually. [Report]
  105. Oates DJ, Berlowitz DR, Glickman ME, et al. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007;55:383. [Abstract]
  106. Ogden C, Carroll M. Prevalence of obesity among children and adolescents: United States, trends 1963–1965 through 2007–2008. NCHS Health E-Stat. 2010 June. [Full text]
  107. Okonofua E, Simpson K, Jesri A, et al. P-93: Clinical inertia in hypertension management: effects on BP control. Am J Hypertens 2005; 18:41A. [Abstract]
  108. ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008; 358:1547. [Full text]
  109. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control—continued disparities in adults: United States, 2005–2006. NCHS Data Brief no 3. Hyattsville, MD: National Center for Health Statistics; 2008. [Full text]
  110. Ostchega Y, Dillon CF, Hughes JP, et al. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc. 2007;55:1056. [Abstract]
  111. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353:487. [PDF]
  112. Ouzan J, Pérault C, Lincoff AM, Carré E, Mertes M. The role of spironolactone in the treatment of patients with refractory hypertension. Am J Hypertens. 2002; 15(4 Pt 1):333. [abstract]
  113. Parchman ML, Pugh JA, Romero RL, Bowers KW. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med. 2007; 5:196. [Abstract]
  114. Parikh NI, Pencina MJ, Wang TJ, et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med 2008; 148:102. [Abstract]
  115. Pencina MJ, D'Agostino RB Sr, Larson MG, et al. Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation 2009; 119:3078. [Full text]
  116. Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al; INVEST Investigators. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003;290:2805. [Abstract]
  117. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood Pressure Monitoring. Task force V: White-coat hypertension. Blood Press Monit. 1999; 4:333. [Abstract]
  118. Pickering TG, Miller NH, Ogedegbe G, et al; American Heart Association; American Society of Hypertension; Preventive Cardiovascular Nurses Association. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008; 52:10. [Full text]
  119. Pickering TG, Hall JE, Appel LJ, et al; Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005; 45:142. [Full text]
  120. Pimenta E, Calhoun DA. Resistant hypertension and aldosteronism. Curr Hypertens Rep. 2007; 9:353. [abstract]
  121. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001;135:825. [Abstract]
  122. Player MS, King DE, Mainous AG 3rd, Geesey ME. Psychosocial factors and progression from prehypertension to hypertension or coronary heart disease. Ann Fam Med. 2007; 5:403. [Full text]
  123. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008;51:960. [Abstract]
  124. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992; 47:1102. [Abstract]
  125. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358:1033. [Abstract]
  126. Quinkler M, Stewart PM. Treatment of primary aldosteronism. Best Pract Res Clin Endocrinol Metab. 2010; 24:923. [abstract]
  127. Qureshi AI, Suri FK, Kirmani JF, et al. Is prehypertension a risk factor for cardiovascular diseases? Stroke. 2005; 36:1859. [Full text]
  128. Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003; 16(11 Pt 1):925. [abstract]
  129. Rhoades R, Planzer R. Human Physiology. 3rd ed. Fort Worth, TX: Saunders College Publishing; 1996.
  130. Robinson SC, Brucer M. Range of normal blood pressure: a statistical and clinical study of 11,383 persons. Arch Int Med. 1939; 64:409.
  131. Rosenthal T, Alter A, Peleg E, Gavish B. Device-guided breathing exercises reduce blood pressure—ambulatory and home measurements. Am J Hypertens 2001; 14:74. [Abstract]
  132. Rothwell PM, Howard SC, Dolan E, et al; ASCOT-BPLA and MRC Trial Investigators. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010; 9:469. [Abstract]
  133. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010; 375:895. [Abstract]
  134. Sacks FM, Svetkey LP, Vollmer WM, et al; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001; 344:3. [abstract]
  135. Safar ME, Rudnichi A, Asmar R. Drug treatment of hypertension: the reduction of pulse pressure does not necessarily parallel that of systolic and diastolic blood pressure. J Hypertens. 2000; 18:1159. [abstract]
  136. Safar ME, Blacher J, Mourad JJ, London GM. Stiffness of carotid artery wall material and blood pressure in humans: application to antihypertensive therapy and stroke prevention. Stroke. 2000; 31:782. [abstract]
  137. Salerno SM, Jackson JL, Berbano EP. Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis. Arch Intern Med. 2005; 165:1686. [Full text]
  138. Sanz J, García-Vera MP, Espinosa R, et al. Psychological factors associated with poor hypertension control: differences in personality and stress between patients with controlled and uncontrolled hypertension. Psychol Rep. 2010; 107:923. [Abstract]
  139. Schein M, Gavish B, Herz M, et al. Treating hypertension with a device that slows and regularizes breathing: a randomized double-blind controlled study. J Hum Hypertens 2001; 15:271. [Full text]
  140. Schmitt KE, Edie CF, Laflam P, et al. Adherence to antihypertensive agents and blood pressure control in chronic kidney disease. Am J Nephrol. 2010;32:541. [Abstract]
  141. Seely EW. Hypertension in pregnancy: a potential window into long-term cardiovascular risk in women. J Clin Endocrinol Metab. 1999;84:1858. [Full text]
  142. Shayne PH, Pitts SR. Severely increased blood pressure in the emergency department. Ann Emerg Med 2003; 41:513. [Abstract]
  143. Standards of medical care in diabetes—2010. Diabetes Care 2010; 33:S11-61. [Full text]
  144. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134:1. [Abstract]
  145. Svarstad BL, Kotchen JM, Shireman TI, et al. The Team Education and Adherence Monitoring (TEAM) trial: pharmacy interventions to improve hypertension control in blacks. Circ Cardiovasc Qual Outcomes. 2009;2:264. [Full text]
  146. Systolic Blood Pressure Intervention Trial (SPRINT). Clinical Trials.gov Identifier: Clinical Trial identifier NCT01206062.. [Clinical Trial] Accessed December 16, 2010.
  147. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413. [Abstract]
  148. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42:1206. [Full text]
  149. Thune JJ, Signorovitch J, Kober L, et al. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction. Hypertension. 2008; 51:48. [Abstract]
  150. Tirosh A, Afek A, Rudich A, et al. Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension. 2010; 56:203. [Abstract]
  151. Toprak A, Wang H, Chen W, et al. Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa Heart Study. J Hypertens. 2009; 27:243. [Abstract]
  152. Turnbull F, Woodward M, Neal B, et al; Blood Pressure Lowering Treatment Trialists' Collaboration. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29:2669. [Abstract]
  153. United States Renal Data System. USRDS 2007 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services; 2007. [Full text]
  154. US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 04-5230; 2004. http://www.ncbi.nlm.nih.gov/books/NBK9630/pdf/TOC.pdf.
    Accessed December 20, 2010. [Full text]
  155. Varma S, et al. “Achieving ABC’s of diabetes care with ‘a team of 4 approach.’ ” WCIR 2010; Abstract 108. [MedPage report]
  156. Vasan RS, Evans JC, Larson MG, et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004; 351:33. [Abstract]
  157. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001; 345:1291. [Full text]
  158. Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358:1682. [Abstract]
  159. Viskoper R, Shapira, Priluck I, et al. Non-pharmacological treatment of resistant hypertensives by device-guided slow breathing exercises. Am J Hypertens 2003; 16:484. [Abstract]
  160. Walsh JM, McDonald KM, Shojania KG, et al. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006; 44:646. [Abstract]
  161. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee Guidelines: new challenges of the old problem. Arch Intern Med. 2004; 164:2126. [Full text]
  162. Weber MA, Bakris GL, Jamerson K, et al; ACCOMPLISH Investigators. Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol. 2010;56:77. [Full Text]
  163. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998; 279:839. [Full text]
  164. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983. [Abstract]
  165. Whooley MA, Avins AL, Miranda J, et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12:439-445. [Abstract]
  166. Williams B, Poulter NR, Brown MJ, et al. The BHS Guidelines Working Party Guidelines for Management of Hypertension: Report of the Fourth Working Party of the British Hypertension Society, 2004—BHS IV. J Hum Hypertens 2004; 18:139. Updated in 2006 [PDF]
  167. Wright JT Jr, Bakris G, Greene T, et al; for the African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002; 288:2421. [Abstract]
  168. Wright JT Jr, Probstfield JL, Cushman WC, et al; ALLHAT Collaborative Research Group. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. Arch Intern Med 2009; 169:832. [Abstract]
  169. Wyse DG, Waldo AL, DiMarco JP, et al; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002; 347:1825. [abstract]
  170. Yoon S, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999–2008. NCHS data brief, no 48. Hyattsville, MD: National Center for Health Statistics. 2010. [Full text]
  171. Zarnke KB, Feagan BG, Mahon JL, Feldman RD. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. Am J Hypertens. 1997; 10:58. [Abstract]
  172. Zimmerman GL, Olsen CG, Bosworth MF. A 'stages of change' approach to helping patients change behavior. Am Fam Physician. 2000; 61:1409. [Full text]
  173. Zweifler AJ, Shahab ST. Pseudohypertension: A new assessment. J Hypertens 1993; 11:1.[Reference]
  174. [No authors listed] Retraction--Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomized controlled trial. Lancet. 2009; 374:1226. [article information; no abstract]
Copyright © 2010-2013  Perelman School of Medicine at the University of Pennsylvania Office of Continuing Medical Education. All rights reserved.